Disparities Observed in Mortality During COVID-19 Pandemic
WEDNESDAY, Oct. 16, 2024 -- During the COVID-19 public health emergency (PHE) period, excess mortality occurred in all racial and ethnic groups, but disparities were observed, according to a study published online Oct. 11 in JAMA Network Open.
Jeremy Samuel Faust, M.D., from Mass General Brigham in Boston, and colleagues characterized overall and age-specific all-cause excess mortality by race and ethnicity during the COVID-19 PHE in a cross-sectional study. Data were included for all U.S. residents and decedents during the COVID-19 PHE period (March 2020 to May 2023).
The researchers found that during the pandemic, there were more than 1.38 million all-cause excess deaths (observed-to-expected ratio, 1.15), corresponding to approximately 23 million years of potential life lost (YPLL). For the total population (all ages), the racial and ethnic groups with the highest observed-to-expected mortality ratios were the American Indian or Alaska Native and Hispanic populations (1.34 and 1.31, respectively). Higher ratios were observed in the U.S. population aged 25 to 64 years (1.20) and were greatest among American Indian or Alaska Native, Hispanic, and Native Hawaiian or Other Pacific Islander groups (1,45, 1.40, and 1.39, respectively). The Black population accounted for 51.1 percent of excess mortality in those younger than 25 years, despite representing 13.8 percent of the population. More than 252,000 (18.3 percent) fewer excess deaths and more than 5.2 million (22.3 percent) fewer YPLL would have occurred if the rate of excess mortality observed among the White population had been observed in the total population.
"The need to address the conditions that create health disparities -- before the next public health crisis -- is evident," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Further Support and Information on COVID-19
Read this next
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.